Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
26/05/2026 07:19
May 26 (Reuters) - Poolbeg Pharma PLC POLB.L: POOLBEG PHARMA PLC - PRE-IND MEETING WITH THE FDA FOR POLB 001 POOLBEG PHARMA PLC - FDA FEEDBACK BROADLY ALIGNED WITH DEVELOPMENT PATHWAY FOR POLB 001 Source text: ID:nRSZ5748Fa Further company coverage: POLB.L ((Reuters.Briefs@thomsonreuters.com))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice
Results for the year ended 31 December 2025
Appointment of Dr Adrian Kilcoyne to SAB